Literature DB >> 16913849

Isolation and comparative characterization of Ki-67 equivalent antibodies from the HuCAL phage display library.

Tiantom Jarutat1, Christian Frisch, Cora Nickels, Hartmut Merz, Achim Knappik.   

Abstract

It has been shown that a repetitive motif with the sequence FKEL(F) within the Ki-67 antigen (pKi-67) serves as an epitope for the Ki-67 antibody and equivalent clones. However, no direct correlation between reactivity towards Ki-67 epitopes and reactivity in formalin-fixed paraffin-embedded (FFPE) tissue could be found. In this study our aim was the isolation and characterization of new monoclonal Ki-67 equivalent antibodies in an in vitro approach. To select pKi-67 reactive phage antibodies, we used a large naive Fab-phage library (Human Combinatorial Antibody Library; HuCAL). We implemented a panning strategy against two different overlapping peptides, both containing the 'FKELF' epitope. ELISA screening of randomly picked phage antibody clones after the third selection round yielded six highly reactive clones against the 'FKELF' epitope, of which five were found to be reactive in FFPE tissue, showing a Ki-67 equivalent staining pattern. Substitutional epitope analysis on peptide arrays of the new recombinant pKi-67 binders and of the established murine clones Ki-67, Mib-1 and Mib-5 were carried out to compare their fine specificities. The results suggest that the lysine residue in the epitope is critical for recognition of Ki-67 antigen in FFPE tissue.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16913849     DOI: 10.1515/BC.2006.123

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  7 in total

1.  Crystallization and preliminary X-ray crystallographic analysis of the sclerostin-neutralizing Fab AbD09097.

Authors:  Verena Boschert; Eva Maria Muth; Achim Knappik; Christian Frisch; Thomas D Mueller
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2015-03-20       Impact factor: 1.056

2.  Isolation and characterization of selective and potent human Fab inhibitors directed to the active-site region of the two-component NS2B-NS3 proteinase of West Nile virus.

Authors:  Sergey A Shiryaev; Ilian A Radichev; Boris I Ratnikov; Alexander E Aleshin; Katarzyna Gawlik; Boguslaw Stec; Christian Frisch; Achim Knappik; Alex Y Strongin
Journal:  Biochem J       Date:  2010-04-14       Impact factor: 3.857

3.  Affinity maturation by targeted diversification of the CDR-H2 loop of a monoclonal Fab derived from a synthetic naïve human antibody library and directed against the internal trimeric coiled-coil of gp41 yields a set of Fabs with improved HIV-1 neutralization potency and breadth.

Authors:  Elena Gustchina; John M Louis; Christian Frisch; Francisco Ylera; Annette Lechner; Carole A Bewley; G Marius Clore
Journal:  Virology       Date:  2009-08-19       Impact factor: 3.616

4.  Natural and man-made V-gene repertoires for antibody discovery.

Authors:  William J J Finlay; Juan C Almagro
Journal:  Front Immunol       Date:  2012-11-15       Impact factor: 7.561

5.  The sclerostin-neutralizing antibody AbD09097 recognizes an epitope adjacent to sclerostin's binding site for the Wnt co-receptor LRP6.

Authors:  V Boschert; C Frisch; J W Back; K van Pee; S E Weidauer; E-M Muth; P Schmieder; M Beerbaum; A Knappik; P Timmerman; T D Mueller
Journal:  Open Biol       Date:  2016-08       Impact factor: 6.411

6.  Generation by phage display and characterization of drug-target complex-specific antibodies for pharmacokinetic analysis of biotherapeutics.

Authors:  Stefan Harth; Andre Ten Haaf; Christian Loew; Christian Frisch; Achim Knappik
Journal:  MAbs       Date:  2018-12-05       Impact factor: 5.857

7.  A Recombinant Positive Control for Serology Diagnostic Tests Supporting Elimination of Onchocerca volvulus.

Authors:  Allison Golden; Eric J Stevens; Lindsay Yokobe; Dunia Faulx; Michael Kalnoky; Roger Peck; Melissa Valdez; Cathy Steel; Potochoziou Karabou; Méba Banla; Peter T Soboslay; Kangi Adade; Afework H Tekle; Vitaliano A Cama; Peter U Fischer; Thomas B Nutman; Thomas R Unnasch; Tala de los Santos; Gonzalo J Domingo
Journal:  PLoS Negl Trop Dis       Date:  2016-01-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.